Which marketing metrics do investors expect from a healthcare startup?
Investors expect a healthcare startup to show what it costs to win a customer, how fast that cost is earned back, whether customers stay, and whether pipeline converts. That means fully loaded CAC, payback on gross margin, cohort retention, stage-by-stage pipeline and channel concentration, each defined once, collected without leaking health data, and reconciled with finance.
- Lead with efficiency and retention: CAC, payback, cohort retention and net revenue retention matter more than traffic.
- Define every metric once and use the same formula in every deck and data room.
- Collect data lawfully; HIPAA tracking guidance or the FTC Health Breach Notification Rule may apply.
- Antifraud rules apply to exempt offerings, and buying fake followers is banned by FTC rule.
- Every practice welcome — retainers from $499/mo, Goals-Driven engagements, Performance-Linked Payout Models available.
- Dallas, Texas LLC
- US client team · Central Time (CST)
- 25+ US healthcare clients
- BAA signed with every client
- HIPAA compliance training across client and delivery teams
- Contracts and invoices in USD
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
What marketing metrics do investors look at in a healthcare startup?
Investors mainly look at whether marketing produces customers efficiently and whether those customers stay. That means customer acquisition cost, payback period, retention or churn, pipeline quality and conversion by stage, sales cycle length, and how concentrated growth is in one channel. They care less about traffic, followers or impressions unless those clearly feed revenue.
Healthcare adds a few twists. Sales cycles into practices and health systems can be long, so investors want to see pipeline that is real rather than hopeful. Consumer health products face limits on ad targeting, so investors ask whether acquisition costs will hold as spend grows. And because health data rules shape what can be tracked, investors increasingly ask how the numbers were collected.
What investors want from marketing data comes down to four questions:
- Efficiency: what does it cost to win a customer, and how fast is that cost earned back?
- Durability: do customers keep using and paying, and does revenue from each cohort grow or shrink?
- Repeatability: can the company grow without the founders in every deal, through channels that scale?
- Credibility: are the numbers defined consistently, collected lawfully and reconcilable to finance?
The rest of this guide covers how to define, present and protect each one. It is about how to report, not what good looks like for your stage. Benchmarks vary widely by business model, buyer and funding stage, so build your case from your own cohorts.
How should a healthcare startup define CAC, payback and lifetime value?
Define each metric once, in writing, with the exact formula and data source, and use the same definition in every board deck and data room. Investors lose trust fast when acquisition cost is calculated one way in one meeting and another way later. Fully loaded definitions, including salaries and tools, are more credible than paid-media-only versions.
| Metric | Formula (plain language) | Common mistake |
|---|---|---|
| Customer acquisition cost (CAC) | Total sales and marketing cost in a period, including people and tools, divided by new customers won in that period | Counting only ad spend, which flatters the number |
| Paid CAC | Paid media cost divided by customers attributed to paid channels | Presenting it as if it were blended CAC |
| CAC payback period | CAC divided by monthly gross margin per new customer, giving months to recover acquisition cost | Using revenue instead of gross margin |
| Customer lifetime value (LTV) | Average gross margin per customer per period multiplied by expected customer lifetime | Assuming a lifetime longer than the company has existed |
| LTV to CAC ratio | Lifetime value divided by CAC | Mixing segments with very different economics in one ratio |
| Net revenue retention | Revenue this period from a starting cohort, including expansion and losses, divided by that cohort's starting revenue | Leaving out churned customers |
Show the definitions on a single slide or appendix page. When a number changes because the definition changed, say so and show both versions for one period. For consumer health businesses, the equivalent of a customer may be a paying subscriber or an active user. Define "active" precisely, such as completed onboarding and used the core feature in the last month.
Gross margin matters more in healthcare than founders often expect. Products that include clinician time, coaching or human support carry delivery costs that pure software does not. Payback calculated on revenue rather than gross margin can look much better than reality, and experienced investors will recalculate it.
Our glossary entries on patient acquisition cost and cost per lead cover the related practice-level measures.
Which metrics matter most for B2B healthtech versus consumer health startups?
B2B healthtech startups are judged mostly on pipeline, sales cycle, win rate, contract value and net revenue retention. Consumer health startups are judged mostly on blended acquisition cost, activation, subscription retention by cohort and payback. Hybrid models, such as products paid by employers but used by individuals, need both sets, reported separately.
| Area | B2B healthtech (selling to practices, systems, payers) | Consumer health and D2C |
|---|---|---|
| Acquisition | Qualified opportunities by source, cost per opportunity, blended CAC | Blended and paid CAC by channel, cost per activated user |
| Conversion | Stage conversion rates, win rate, sales cycle length | Visit to sign-up, sign-up to activation, trial to paid |
| Value | Average contract value, implementation time, expansion revenue | Average order or subscription value, purchase frequency |
| Retention | Logo retention, net revenue retention, renewal rate | Monthly cohort retention curves, subscriber churn |
| Concentration risk | Share of pipeline from top accounts or one referral partner | Share of new customers from one ad platform |
| Efficiency | CAC payback in months on gross margin | CAC payback in months on gross margin |
Channel concentration deserves its own slide. A consumer health brand that wins most customers through one ad platform is exposed to policy changes on health targeting. A B2B company whose pipeline comes mostly from one channel partner is exposed if that partner changes direction. Investors do not expect perfect diversification at an early stage. They do expect founders to know the risk and have a plan to reduce it.
For marketplaces and app stores, retention and review standing can change when platform policies change. Describe that exposure honestly and check each platform's current policy.
How should a healthcare startup present pipeline and sales-cycle data?
Present pipeline as stage-by-stage data from the CRM, with clear entry rules for each stage, and show how past pipeline actually converted. Investors discount pipeline heavily unless they can see historical conversion and cycle length. Cohort views, grouping deals by the month they entered the pipeline, are more convincing than a single total.
- Stage definitions: what must be true for a deal to enter each stage, such as a completed discovery call with a confirmed budget owner.
- Historical conversion: for deals that entered a stage in past quarters, how many moved forward, stalled or were lost.
- Cycle length: median days from first meeting to signed contract, by segment. Health systems and small practices should not be averaged together.
- Source: which channel each opportunity came from, using the same attribution rules every quarter.
- Loss reasons: the top reasons deals were lost, such as security review, budget timing or a competing internal project.
For consumer businesses, the equivalent is a funnel by monthly cohort: visitors, sign-ups, activated users and paying customers, with retention curves for each paying cohort. A strong month of sign-ups means little if those users did not activate.
Tie marketing spend to these numbers. A clear view of how the marketing budget is split by channel and stage lets investors see which spend produces pipeline and which is still experimental.
How should a healthcare startup collect marketing data without privacy problems?
Collect marketing data in a way that would survive a privacy review in diligence: keep ad pixels and analytics tags away from pages and events that reveal health information, use consent and server-side setups where possible, and report in aggregate. Investors and acquirers increasingly ask how growth data was gathered, because privacy problems become their liability after closing.
The rules depend on your model. If you are a HIPAA covered entity or business associate, HHS guidance on online tracking technologies says tracking on authenticated pages, such as patient portals, can involve protected health information. A federal court in June 2024 vacated the part addressing certain unauthenticated public pages, but the rest remains guidance. If you are a consumer health app outside HIPAA, the FTC's Health Breach Notification Rule, amended in 2024, covers many health apps and treats an unauthorized disclosure of health data as a breach.
Practical setup
- Track conversions as non-sensitive events, such as "demo requested" or "account created", without condition, medication or symptom details.
- Keep marketing tags off intake forms, symptom questions, booking steps and logged-in areas.
- Use vendors that will sign a BAA where protected health information could be involved.
- Document the setup, so you can hand diligence a clear data map instead of a scramble.
Our HIPAA-safe website tracking guide shows typical setups. Confirm the approach that fits your company with privacy counsel.
What makes marketing metrics misleading to investors?
Marketing metrics mislead investors when they are inflated, selectively chosen, inconsistently defined or presented without context. Vanity numbers such as followers or downloads, bought engagement, best-cohort-only charts and paid-only acquisition costs all fall in this group. Beyond losing trust, some of these practices raise legal issues under FTC and securities rules.
Common problems
- Bought social proof. The FTC's rule on consumer reviews and testimonials, effective October 2024, bans buying or selling fake indicators of social media influence, such as bot-generated followers or views, when used to misrepresent influence for a commercial purpose. It also bans fake reviews.
- Cherry-picked cohorts. Showing only the best month's retention curve without the others.
- Shifting definitions. Changing what counts as active or as a customer between rounds without saying so.
- Unreconciled numbers. Marketing-reported revenue that does not match the finance system.
- Unsupported outcome claims. Health outcome figures in an investor deck that would not meet the evidence standard expected in advertising.
Securities rules still apply
Startup fundraising usually relies on exemptions from registration, but the SEC's exempt offerings FAQ states that all securities transactions, even exempt ones, are subject to the antifraud provisions of federal securities law. Statements about the company, written or spoken, must not be misleading. Marketing teams should also know that a Rule 506(b) offering does not allow general solicitation or advertising of the securities. Do not post about an active raise on social media or the website without counsel's approval.
What should a board-ready marketing report include?
A board-ready marketing report should fit on a few pages: a one-line summary of the month, the core efficiency and retention metrics against plan, pipeline or funnel by stage and source, what changed and why, and decisions needed from the board. Use the same layout every month so trends are visible without explanation.
| Section | What it shows | Format |
|---|---|---|
| Summary | The month in one or two sentences, and any decision needed | Short text at the top |
| Efficiency | Blended CAC, paid CAC, payback period against plan | Small table with the last several periods |
| Pipeline or funnel | Stage counts and conversion, by source | Stage table or cohort chart |
| Retention | Logo or subscriber retention, net revenue retention | Cohort table |
| Channel mix | Spend and results by channel, concentration risk | Table with a short note |
| Experiments | What was tested, what was learned, what stops or scales | Bullet list |
| Next month | Goals, budget changes, risks | Bullet list |
Every number should trace back to a defined metric and a named system of record. Keep a separate appendix with metric definitions, attribution rules and any changes made.
Habits that build investor trust
- Report bad months the same way as good ones. A missed target explained plainly does less damage than a changed layout that hides it.
- Separate experiments from the core plan. Label new channels as tests until they have produced customers for several months.
- Reconcile with finance before every meeting. Customer counts and revenue in the marketing report should match the accounting system.
- Name owners. Each goal for next month should have one accountable person.
Building this report is part of the fractional CMO role at Ichelon Consulting US. Santosh Reddy, Partner, Ichelon Consulting US, serves as fractional CMO. The Growth plan at $1,500 a month includes a monthly board-ready marketing report, and Advisory starts at $1,000 a month. See the fractional CMO for healthcare companies page or book a call with the US team to review your current investor reporting.
Related pages from the US team
Fractional CMO for healthcare companies
Board-ready marketing reporting and senior leadership.
Healthcare startup marketing budget
How to size and split early marketing spend.
Digital health marketing statistics
Public data points for digital health startup marketing.
Fractional CMO cost
What a fractional CMO costs and what each plan includes.
Every practice welcome — Goals-Driven engagements from $499/mo
We benchmark your last 90 days, agree monthly goals with you, and track them live on Ichelon Agency OS with a report every Monday. Performance-Linked Payout Models are available. Our US leadership is based in Dallas, and strategy calls run in US business hours.
Common questions
What is the most important marketing metric for healthcare startup investors?
There is rarely one. Most investors look first at customer acquisition cost together with payback period and retention, because the three show whether growth is efficient and durable. A low acquisition cost means little if customers leave quickly. Present them together, defined consistently, with several periods of history so trends are clear.
Should CAC include salaries and tools?
For blended or fully loaded CAC, yes. Include sales and marketing salaries, contractor and agency fees, tools and media spend, then divide by new customers in the period. Paid CAC, using media cost only, can be shown alongside it but should be clearly labeled. Investors tend to distrust acquisition costs that leave out people and tools.
Do investors care about social media followers?
Only if followers clearly turn into customers or lower acquisition cost. On their own, followers, downloads and impressions are weak signals. Never inflate them. The FTC's rule on consumer reviews and testimonials, effective October 2024, bans buying fake indicators of social media influence, such as bot followers or views, used to misrepresent influence commercially.
How should a B2B healthtech startup show pipeline to investors?
Show pipeline by stage from the CRM, with written entry rules for each stage, historical conversion rates, median sales cycle by segment, and source for each opportunity. Grouping deals by the month they entered the pipeline helps investors see how earlier pipeline actually converted, which makes current pipeline more believable.
Can marketing teams post about a startup's fundraising round?
Only with counsel's approval. Many startup rounds rely on Rule 506(b), which does not allow general solicitation or advertising of the securities. Other exemptions have different conditions. And the SEC says all securities transactions, even exempt ones, are subject to antifraud provisions, so statements about the company must not be misleading.
Why do investors ask how marketing data was collected?
Because privacy problems become the investor's or acquirer's risk after closing. If ad pixels sent health information to third parties, the company may face exposure under HIPAA guidance or the FTC Health Breach Notification Rule. A documented, privacy-safe tracking setup and aggregate reporting make diligence faster and the numbers more trustworthy.
A note on this guide: it explains marketing practice, not legal advice. Rules on privacy, advertising and insurance change and vary by state, so confirm anything compliance-related with your own counsel.
Preparing marketing numbers for a raise or board meeting?
Book a 30-minute call with the US team. We'll review your metric definitions, reporting and tracking setup before investors do.
We cover every stage, from first search to repeat visit
- 0Foundations
- 1Demand gen
- 2Capture
- 3Lead quality
- 4Lead mgmt
- 5Scheduling
- 6Show-up
- 7Conversion
- 8Retention
We work across all nine stages, from foundations to past patients, and fix the stage that leaks first. Our own software runs the work, and every stage is reported against a monthly target on Ichelon Agency OS.
See all nine stages and the tool behind each one →